Flavospas 10 Tablets

Babies: Not recommended. Lactating mothers: This tablet may or may not be safe if prescribed in lactating mothers. Please consult your doctor. Pregnancy: This tablet may or may not be safe if prescribed in pregnancy.
Please consult your doctor. Driving: This tablet may affect concentration, making you feel sleepy and dizzy. Do not drive after taking this tablet.
Alcohol: This tablet is unsafe when taken with alcohol as it may worsen the state of drowsiness. Please consult your doctor.
Kidney: Dose adjustment is required in patients with kidney disorders. Please consult your doctor. Liver: Dose adjustment is required in patients with liver disorders.
Please consult your doctor..

Nausea Vomiting Dry mouth Abdominal pain Constipation Headache Drowsiness Dizziness Palpitations Increased heart rate Blurred vision Dryness of skin Skin rashes.

Flavospas tablet belongs to the antispasmodic agent used in the symptomatic treatment of urinary incontinence, dysuria, nocturia, urethritis, muscle spasms, and painful urination. It works by relaxing the smooth muscles of the urinary tract by inhibiting a specific enzyme, thereby controlling the symptoms..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• This tablet is used in the symptomatic treatment of urinary incontinence, dysuria, nocturia, urethritis, muscle spasms, and painful urination. • This tablet can affect your concentration by making you feel sleepy or dizzy; hence it is advisable not to drive or do any machine work while on this medication.
• Do not consume alcohol while you are on this medication, as it may worsen the state of drowsiness. • Always complete the course of the prescribed medication.
Do not skip any of the doses. • Let your doctor know if you are pregnant or intend to be pregnant or breastfeeding..

• Flavospas + Pramlintide: Either increases effects of the other by pharmacodynamic synergism. Enhances inhibition of gi motility. • Flavospas + Aripiprazole: Aripiprazole increases the effects of flavospas by pharmacodynamic synergism.
May enhance the risk of hypoglycemia. • Flavospas + Haloperidol: Flavospas decreases levels of haloperidol by inhibiting its gi absorption. • Flavospas + Atenolol: Flavospas increases the effects of atenolol by pharmacodynamic antagonism..